# Optex Systems Holdings Inc: overview OPXS · Nasdaq · CIK 1397016 · [Technology](/sectors/technology.md) · fiscal year ends Sep 28 Pages: [Overview](/companies/opxs.md) · [Financials](/companies/opxs/financials.md) · [Filings](/companies/opxs/filings.md) · [Insiders](/companies/opxs/insiders.md) Latest reported revenue: [$9.7m](/filings/0001493152-26-037119.md) for Q3 FY2026, three months to 2026-06-28, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-037119). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [9.4 d](/filings/0001493152-25-028071.md) | [8.2](/filings/0001493152-26-006128.md) | [10.7](/filings/0001493152-26-022219.md) | [11.1](/filings/0001493152-26-037119.md) | [11.3 d](/filings/0001493152-25-028071.md) | [9.1](/filings/0001493152-26-006128.md) | [9.6](/filings/0001493152-26-022219.md) | [9.7](/filings/0001493152-26-037119.md) | | Gross margin | % | [25.5% d](/filings/0001493152-25-028071.md) | [26.0%](/filings/0001493152-26-006128.md) | [31.3%](/filings/0001493152-26-022219.md) | [28.5%](/filings/0001493152-26-037119.md) | [30.1% d](/filings/0001493152-25-028071.md) | [22.9%](/filings/0001493152-26-006128.md) | [35.2%](/filings/0001493152-26-022219.md) | [34.2%](/filings/0001493152-26-037119.md) | | Operating margin | % | [13.7% d](/filings/0001493152-25-028071.md) | [11.2%](/filings/0001493152-26-006128.md) | [20.8%](/filings/0001493152-26-022219.md) | [17.2%](/filings/0001493152-26-037119.md) | [18.3% d](/filings/0001493152-25-028071.md) | [1.6%](/filings/0001493152-26-006128.md) | [17.3%](/filings/0001493152-26-022219.md) | [14.3%](/filings/0001493152-26-037119.md) | | Net margin | % | [10.7% d](/filings/0001493152-25-028071.md) | [10.3%](/filings/0001493152-26-006128.md) | [16.5%](/filings/0001493152-26-022219.md) | [13.6%](/filings/0001493152-26-037119.md) | [9.1% d](/filings/0001493152-25-028071.md) | [2.6%](/filings/0001493152-26-006128.md) | [13.9%](/filings/0001493152-26-022219.md) | [13.2%](/filings/0001493152-26-037119.md) | | Diluted EPS | $ per share | not reported | [0.12](/filings/0001493152-26-006128.md) | [0.26](/filings/0001493152-26-022219.md) | [0.22](/filings/0001493152-26-037119.md) | not reported | [0.03](/filings/0001493152-26-006128.md) | [0.19](/filings/0001493152-26-022219.md) | [0.18](/filings/0001493152-26-037119.md) | | Free cash flow | $m | [0.5 d](/filings/0001493152-25-028071.md) | [2.5](/filings/0001493152-26-006128.md) | [1.1 d](/filings/0001493152-26-022219.md) | [1.4 d](/filings/0001493152-26-037119.md) | [1.5 d](/filings/0001493152-25-028071.md) | [(0.5)](/filings/0001493152-26-006128.md) | [(1.6) d](/filings/0001493152-26-022219.md) | [2.1 d](/filings/0001493152-26-037119.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-10-03) | FY2022 (2022-10-02) | FY2023 (2023-10-01) | FY2024 (2024-09-29) | FY2025 (2025-09-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [18.2](/filings/0001493152-22-035871.md) | [22.4](/filings/0001493152-23-045259.md) | [25.7](/filings/0001493152-24-050771.md) | [34.0](/filings/0001493152-25-028071.md) | [41.3](/filings/0001493152-25-028071.md) | | Gross margin | % | [13.8%](/filings/0001493152-22-035871.md) | [21.9%](/filings/0001493152-23-045259.md) | [25.8%](/filings/0001493152-24-050771.md) | [28.0%](/filings/0001493152-25-028071.md) | [29.2%](/filings/0001493152-25-028071.md) | | Operating margin | % | [(2.7%)](/filings/0001493152-22-035871.md) | [7.4%](/filings/0001493152-23-045259.md) | [10.9%](/filings/0001493152-24-050771.md) | [14.2%](/filings/0001493152-25-028071.md) | [17.3%](/filings/0001493152-25-028071.md) | | Net margin | % | [11.7%](/filings/0001493152-22-035871.md) | [5.7%](/filings/0001493152-23-045259.md) | [8.8%](/filings/0001493152-24-050771.md) | [11.1%](/filings/0001493152-25-028071.md) | [12.5%](/filings/0001493152-25-028071.md) | | Diluted EPS | $ per share | [0.18](/filings/0001493152-22-035871.md) | [0.16](/filings/0001493152-23-045259.md) | [0.34](/filings/0001493152-24-050771.md) | [0.55](/filings/0001493152-25-028071.md) | [0.74](/filings/0001493152-25-028071.md) | | Free cash flow | $m | [0.2](/filings/0001493152-22-035871.md) | [1.8](/filings/0001493152-23-045259.md) | [(0.7)](/filings/0001493152-24-050771.md) | [1.1](/filings/0001493152-25-028071.md) | [6.4](/filings/0001493152-25-028071.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/opxs/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $8.9m | 634,671 | | Added +236,523 | | [Topline Capital Management, LLC](/funds/1792549.md) | 2026-06-30 | $6.3m | 449,363 | | Reduced −130,000 | | [PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.](/funds/1238990.md) | 2026-06-30 | $4.8m | 339,740 | | Added +16,265 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $3.2m | 225,007 | | Reduced −30,865 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.1m | 218,622 | | Added +19,817 | | [Archon Capital Management LLC](/funds/1398825.md) | 2026-06-30 | $2.8m | 196,124 | | Added +538 | | [Meros Investment Management, LP](/funds/1911372.md) | 2026-06-30 | $1.3m | 95,312 | | New +95,312 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $933.7k | 66,501 | | Added +3,776 | | [Mink Brook Asset Management LLC](/funds/2052205.md) | 2026-06-30 | $873.8k | 62,284 | | Reduced −2,555 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $722.8k | 51,518 | | Reduced −47,458 | ## Recent filings [All 451 filings](/companies/opxs/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-11 | 16:05 ET | [10-Q](/filings/0001493152-26-037119.md) | Quarterly report, period 2026-06-28 | 0001493152-26-037119 | | 2026-08-11 | 16:05 ET | [8-K](/filings/0001493152-26-037114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037114 | | 2026-07-20 | 17:02 ET | [8-K](/filings/0001493152-26-033931.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-033931 | | 2026-07-01 | 09:30 ET | [8-K](/filings/0001493152-26-031452.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-031452 | | 2026-06-17 | 16:05 ET | [8-K](/filings/0001493152-26-029080.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-029080 | | 2026-05-12 | 06:02 ET | [8-K](/filings/0001493152-26-022360.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022360 | | 2026-05-11 | 16:00 ET | [10-Q](/filings/0001493152-26-022219.md) | Quarterly report, period 2026-03-29 | 0001493152-26-022219 | | 2026-03-09 | 16:18 ET | [8-K](/filings/0001493152-26-009373.md) | 5.07 Shareholder vote results | 0001493152-26-009373 | | 2026-02-11 | 09:05 ET | [8-K](/filings/0001493152-26-006129.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006129 | | 2026-02-11 | 09:00 ET | [10-Q](/filings/0001493152-26-006128.md) | Quarterly report, period 2025-12-28 | 0001493152-26-006128 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 28, 2025](/filings/0001493152-25-028071.md), filed Dec 17, 2025. ## Forecast league Q4 FY2026, the quarter ended 2026-09-28, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/682f79a5-3cb5-4b0d-b6a1-f59b9f1565aa) ## About the filer - CIK: 1397016 - Tickers: OPXS - Exchange: Nasdaq - SIC code: 3827 Optical Instruments & Lenses - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.